Trials / Completed
CompletedNCT00976482
Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,745 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to collect mid-term clinical outcome in a group of patients implanted with permanent pacemaker (PM) according to real-life clinical practice in a multicenter and international environment.
Detailed description
The principal objective of the OPTI-MIND study is to collect data on two-year all-cause mortality in a general population implanted with a PM according to current clinical practice. Additionally, the study aims to stratify the outcome by both known patient-related risk factors and by physiologic pacing mode setting (a specifically defined PM programming). Stratification will be done for pre-specified classes of patients on the basis of their primary rhythm disease.
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2009-09-14
- Last updated
- 2017-02-01
- Results posted
- 2016-12-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00976482. Inclusion in this directory is not an endorsement.